CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-YL-PHENYL)-N4[2-(PROPANE-2-SULFONYL)-PHENYL]-PYRIMIDINE-2,4-DIAMINE

The present invention describes a process for preparing 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-diamine di-hydrochloride salt and crystalline form of 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-di...

Full description

Saved in:
Bibliographic Details
Main Authors WAYKOLE LILADHAR MURLIDHAR, KARPINSKI PIOTR H, FENG LILI, GONG BAOQING
Format Patent
LanguageEnglish
Korean
Published 29.11.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention describes a process for preparing 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-diamine di-hydrochloride salt and crystalline form of 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-diamine.
AbstractList The present invention describes a process for preparing 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-diamine di-hydrochloride salt and crystalline form of 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-diamine.
Author GONG BAOQING
KARPINSKI PIOTR H
FENG LILI
WAYKOLE LILADHAR MURLIDHAR
Author_xml – fullname: WAYKOLE LILADHAR MURLIDHAR
– fullname: KARPINSKI PIOTR H
– fullname: FENG LILI
– fullname: GONG BAOQING
BookMark eNqNi00KwjAUhLvQhX93KLhR8IGm7QFCm9JgmheSCgaRUiSupC3US3hrU_UAwsAMM9_Mg0nbtW4WvFJtTUWF4JKFOerShJiHCaSFQI0gCWwIcINKo8KzhQRKVhVWQAyKK6Z5xqXPvlAFk1ZsQcYXfxp5KhkQMCeR42f5EldQVvNyPPp5F0PGaenzMpjem8fgVj9fBOucVWkBru9qN_TNzbXuWR812R-iUXtCaPQf9QbN00CK
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20130130022A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20130130022A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:51:58 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20130130022A3
Notes Application Number: KR20137018605
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131129&DB=EPODOC&CC=KR&NR=20130130022A
ParticipantIDs epo_espacenet_KR20130130022A
PublicationCentury 2000
PublicationDate 20131129
PublicationDateYYYYMMDD 2013-11-29
PublicationDate_xml – month: 11
  year: 2013
  text: 20131129
  day: 29
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies NOVARTIS AG
RelatedCompanies_xml – name: NOVARTIS AG
Score 2.8778374
Snippet The present invention describes a process for preparing 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-diamine...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-YL-PHENYL)-N4[2-(PROPANE-2-SULFONYL)-PHENYL]-PYRIMIDINE-2,4-DIAMINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131129&DB=EPODOC&locale=&CC=KR&NR=20130130022A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9zivqmU_FjSkEZCh7Omu7jYcjWDzrXNqHtZEVk2DYDUbbhKv4N_tde6qZ7GvThmksOeuVy90tyF0IuUiFoqjVSqFZf6kBFmkAjFQ2Iq_KGypEmYk1mI7teze7Th4E2KJD3RS5MXif0Ky-OiBaVoL1n-Xw9_V_EMvKzlbOb-BWbJvdW2DIqc3Qsa8cggDY6LZMzg-kVXW_1_Irn5zz5oMtqr5F1DKTr0h7Mx47MS5kuOxVrh2xwlDfOdknhbVIiW_ri7rUS2XTnW95Izq1vtke-dT8KwjbCb89UEL25gcIsRQPddpjPwFPhUoVuwLjPOBtEoIFrhnbkAAXe5YjYjK6HNDZw2_Qi5wo8-oSDZP-2Z4IKQd-xWM757fEMPPJxesOByL6mYCDyR3qfnFtmqNuA3zT8U-Gw5y8r4O6AFMeTsTgkChUYgqUIWkYjldbwr2FERJPbWDSTUUrj5IiUV0k6Xs0-IdvyVebuqc0yKWYfn-IUnXgWn-W6_wG5cJVF
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9zivNNp-LH1IIyFDycNZ3dw5CtH3SubUpbZUVk2DYFUbbhKv4N_tde6qZ7GuThyCWBXrjc_dLcHSFnKec0VdQUGo2XW6A8TUBNuQpxQ1SozBQeKyIa2XGb1gO9HyiDEnmfx8IUeUK_iuSIqFEJ6ntenNeT_0ssvXhbOb2KX7FrfGeGbb0-Q8cidwwCaL3bNjymM62uae2-X3f9gicamqzOCllFJ1sV9Q6Mx66IS5ksGhVzk6x5uN4o3yKlt3GVVLR57bUqWXdmv7yRnGnfdJt8a34UhB2E364hIXpzAomZkgKaZTOfgSvDuQy9gHk-89ggAgUcI7QiGyh4PQ8Rm95zkcYOzzLcyL4Alz7hJDG-4xogQ_Bgm6zg_I54Bi_y8XjDici-pKAj8kd6h5yaRqhZgN80_BPhsO8vCuBml5RH4xHfIxLl6IKlCFqyTKZN3DX0iGhyHfNWkqU0TvZJbdlKB8vZJ6RihY49RLn0D8mGYIk4PrlVI-X845MfoUHP4-NiH34A4y-YNQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTALLINE+FORMS+OF+5-CHLORO-N2-%282-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-YL-PHENYL%29-N4%5B2-%28PROPANE-2-SULFONYL%29-PHENYL%5D-PYRIMIDINE-2%2C4-DIAMINE&rft.inventor=WAYKOLE+LILADHAR+MURLIDHAR&rft.inventor=KARPINSKI+PIOTR+H&rft.inventor=FENG+LILI&rft.inventor=GONG+BAOQING&rft.date=2013-11-29&rft.externalDBID=A&rft.externalDocID=KR20130130022A